Diker Management’s ANI Pharmaceuticals ANIP Stock Holding History

Diker Management’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,486	Closed	-$207K	–	33
2021 Q4	$207K	Buy	+4,486	New	+$193K	0.14%	36
2020 Q2	–	Sell	-7,411	Closed	-$302K	–	38
2020 Q1	$302K	Sell	7,411 -1,190	-14%	-$63.3K	0.13%	29
2019 Q4	$530K	Buy	8,601 +210	+3%	+$13.9K	0.34%	21
2019 Q3	$612K	Hold	8,391	–	–	0.4%	20
2019 Q2	$690K	Hold	8,391	–	–	0.29%	21
2019 Q1	$592K	Hold	8,391	–	–	0.36%	24
2018 Q4	$378K	Buy	8,391 +1,410	+20%	+$73.9K	0.16%	43
2018 Q3	$395K	Hold	6,981	–	–	0.14%	40
2018 Q2	$466K	Hold	6,981	–	–	0.17%	41
2018 Q1	$406K	Sell	6,981 -214	-3%	-$13.6K	0.14%	47
2017 Q4	$464K	Buy	7,195 +145	+2%	+$9.02K	0.17%	50
2017 Q3	$370K	Hold	7,050	–	–	0.15%	47
2017 Q2	$330K	Hold	7,050	–	–	0.15%	49
2017 Q1	$349K	Sell	7,050 -1,040	-13%	-$58.4K	0.16%	47
2016 Q4	$490K	Sell	8,090 -1,720	-18%	-$105K	0.21%	42
2016 Q3	$651K	Sell	9,810 -1,090	-10%	-$68.2K	0.23%	37
2016 Q2	$608K	Hold	10,900	–	–	0.24%	36
2016 Q1	$367K	Buy	10,900 +2,300	+27%	+$78K	0.14%	38
2015 Q4	$388K	Hold	8,600	–	–	0.11%	64
2015 Q3	$340K	Buy	+8,600	New	+$489K	0.08%	83

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Diker Management's ANIP Position: Q1 2022 in Review

Diker Management sold out of ANI Pharmaceuticals (ANIP) in Q1 2022, closing a stake of 4,486 shares — an estimated $207K sold.

Diker Management first reported a position in ANIP in Q3 2015 and held it in 20 quarters. The position peaked at $690K in Q2 2019. 126 funds tracked by Wall St. Rank hold ANIP as of Q1 2022.

Diker Management reported no remaining ANI Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
Diker Management sold 4,486 ANI Pharmaceuticals shares in Q1 2022, an estimated $207K.
Diker Management first reported a position in ANI Pharmaceuticals in Q3 2015 and held it in 20 quarters.
Diker Management's ANI Pharmaceuticals position peaked at $690K in Q2 2019.
126 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2022.

Based on Diker Management's 13F filing for Q1 2022, filed 16 May 2022.